CELESTIAL

The Exchange had sought clarification from Celestial Biolabs Limited with respect to announcement dated 03-09-2022 regarding Appointment.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer:1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authorityThe response of the company is attached.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to announcement dated 03-Sep-2022 informing about Appointment.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.

Significant movement in price has been observed in Celestial Biolabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Celestial Biolabs Limited has submitted their response.

Significant movement in price has been observed in Celestial Biolabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

CELESTIAL: Celestial Biolabs Limited had informed the Exchange regarding Appointment of Mr Hardeep Choudhary as Company Secretary & Compliance Officer of the company w.e.f. Jun 04, 2019. On basis of above the Company was required to clarify following: 1. Whether intimated in 24hrs 2. Brief profile (in case of appointment) The response of the Company is attached.

Celestial Biolabs Limited has informed the Exchange regarding Appointment of Mr Hardeep Choudhary as Company Secretary & Compliance Officer of the company w.e.f. Jun 04, 2019. On basis of above the Company is required to clarify following: 1. Whether intimated in 24hrs2. Brief profile (in case of appointment)The response of the Company is awaited.

CELESTIAL:The Exchange had sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stoc

CELESTIAL:The Exchange has sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stoc